All In Biotech

Drug Trial Radar · NCT06613698

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

A Dose-Finding, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of GSK4532990 for Steatohepatitis in Adults With Alcohol-related Liver Disease (ALD)

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

350

Planned (sponsor's estimate)

Start

Sep 27, 2024

Primary completion

Nov 26, 2027

Study completion Mar 2, 2029

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Sep 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.

Conditions

  • Liver Diseases, Alcoholic

Interventions

  • GSK4532990Drug

    GSK4532990 will be administered

  • PlaceboDrug

    Placebo will be administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs) and serious adverse events (SAEs)Time frame: Up to 8 weeks
  2. Number of participants with potentially clinically relevant changes in electrocardiogram (ECG), vital signs, and clinical laboratory tests.Time frame: Up to 8 weeks
  3. Change from baseline in Liver Stiffness measurement (LSM) reduction using FibroScan® at Week 52 (kiloPascal)Time frame: Baseline (Day 1) and at Week 52

Locations

150 sites in 19 countries. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Chandler, Arizona · Recruiting

  • GSK Investigational Site

    Phoenix, Arizona · Recruiting

  • GSK Investigational Site

    Tucson, Arizona · Recruiting

  • GSK Investigational Site

    Tucson, Arizona · Recruiting

  • GSK Investigational Site

    Coronado, California · Recruiting

  • GSK Investigational Site

    Lancaster, California · Recruiting

  • GSK Investigational Site

    Los Angeles, California · Recruiting

  • GSK Investigational Site

    Los Angeles, California · Recruiting

  • GSK Investigational Site

    Pasadena, California · Recruiting

  • GSK Investigational Site

    Sacramento, California · Recruiting

  • GSK Investigational Site

    Brandon, Florida · Recruiting

  • GSK Investigational Site

    Miami, Florida · Recruiting

  • GSK Investigational Site

    Miami Lakes, Florida · Recruiting

  • GSK Investigational Site

    Atlanta, Georgia · Recruiting

  • GSK Investigational Site

    Indianapolis, Indiana · Recruiting

  • GSK Investigational Site

    Topeka, Kansas · Recruiting

  • GSK Investigational Site

    Marrero, Louisiana · Recruiting

  • GSK Investigational Site

    Detroit, Michigan · Recruiting

  • GSK Investigational Site

    Las Vegas, Nevada · Recruiting

  • GSK Investigational Site

    New York, New York · Recruiting

  • GSK Investigational Site

    Chapel Hill, North Carolina · Recruiting

  • GSK Investigational Site

    Cleveland, Ohio · Recruiting

  • GSK Investigational Site

    Philadelphia, Pennsylvania · Recruiting

  • GSK Investigational Site

    Hermitage, Tennessee · Recruiting

  • GSK Investigational Site

    Arlington, Texas · Recruiting

  • GSK Investigational Site

    Austin, Texas · Recruiting

  • GSK Investigational Site

    Dallas, Texas · Recruiting

  • GSK Investigational Site

    Dallas, Texas · Recruiting

  • GSK Investigational Site

    Fort Worth, Texas · Recruiting

  • GSK Investigational Site

    Georgetown, Texas · Recruiting

  • GSK Investigational Site

    McAllen, Texas · Completed

  • GSK Investigational Site

    San Antonio, Texas · Recruiting

  • GSK Investigational Site

    Richmond, Virginia · Recruiting

  • GSK Investigational Site

    Richmond, Virginia · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    Buenos Aires, Argentina · Recruiting

  • GSK Investigational Site

    Ciudad Autonoma de Buenos Aire, Argentina · Recruiting

  • GSK Investigational Site

    Ciudad AutOnoma de Buenos Aire, Argentina · Recruiting

Showing 40 of 150 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.